Stock thesis
Danaher Corporation
Start with the strongest observed signals, the evidence that could challenge them, and the next source-backed checks.
Danaher provides life-science, diagnostics, and biotechnology tools.
Neutral synthesis
Research orientation
Observed facts, not a rating
Why this name is here
Observed evidence
4 tracked funds report DHR in their latest available 13F,
representing $365.1M of combined reported value on this page.
- 1 fund reports a new or increased share count in a comparable filing.
- 1 fund reports it at 5% or more of the portfolio.
Counter-evidence
What could change the view
3 tracked funds report a decreased or absent position in the latest comparable filing. Check the size and timing before interpreting the change.
- 13F positions are delayed and exclude short positions and many non-US assets.
- Financial, insider, earnings, or volatility evidence may be missing or point in another direction.
Continue the work
Next research checks
13F holders
Rows are narrowed by movement, fund type, and position size.
4 holders
No holders match this filter.
Try another movement slice or return to the full holder table.
Show all holders
SEC fundamentals
Financials
Companyfacts
No published earnings analysis yet
We publish a cited report after an eligible official earnings filing is accepted and passes validation.
